Valproate Semisodium

丙戊酸半钠

Report date: 2025/05/21 20:00:31
NME

Base Information

Drug NameValproate Semisodium
Drug Alias Nameバルプロ酸セミナトリウムvalproate semisodiumDivalproex sodiumDepakoteErgenyl +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-amino-N-butyrate transaminase inhibitors
TargetsGamma-amino-N-butyrate transaminase
Therapy Area/IndicationsPsychotic DisordersBipolar DisorderSeizures +[6] 
Global Approved IndicationsBipolar DisorderMigraine DisordersEpilepsy
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1983/03/10
Country/TerritoryUnited StatesIndiaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesAbbvie IncZhejiang Huahai Pharmaceutical Co LtdHenan Zhongshuai Pharmaceutical Technology Co Ltd
Inactive CompaniesSandozMylan Pharmaceuticals IncTeva Pharmaceuticals Usa Inc +[4] 
Active IndicationsPsychotic DisordersBipolar DisorderSeizures +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN03AG01
Related LinksWikipediaDrugBankKEGG